Isao Miyazaki

977 citations
35 papers · 651 indexed · h-index 12
Topics
Genetic and Kidney Cyst Diseases (8 papers)Renal and related cancers (6 papers)Viral-associated cancers and disorders (5 papers)
Partner nations
JapanCanadaUnited States

In The Last Decade

Isao Miyazaki

33 papers receiving 632 citations

Peers

Isao Miyazaki
Comparison fields: 5 of 80
  • Oncology 251
  • Molecular Biology 215
  • Genetics 172
  • Pathology and Forensic Medicine 99
  • Immunology 99
Replace Hiroaki Ohnishi with:
Hiroaki Ohnishi Japan
Alexandros Spyridonidis Greece
Ravindran Ankathil Malaysia
C Wiltschke Austria
Ivan Ngai United States
Sei Kyung Chang South Korea
Katsumi Tsukazaki Japan
Caroline Raynal France
Kyung Whan Min United States
W E Grizzle United States
Isao Miyazaki relative to Hiroaki Ohnishi Japan Hiroaki Ohnishi's profile →
Citations per field
00.5×3.8×
Hiroaki Ohnishi · 1×
Citations per year

Countries citing papers authored by Isao Miyazaki

Since Specialization
Citations

This map shows the geographic impact of Isao Miyazaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isao Miyazaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isao Miyazaki more than expected).

Fields of papers citing papers by Isao Miyazaki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isao Miyazaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isao Miyazaki. The network helps show where Isao Miyazaki may publish in the future.

Co-authorship network of co-authors of Isao Miyazaki

This figure shows the co-authorship network connecting the top 25 collaborators of Isao Miyazaki. A scholar is included among the top collaborators of Isao Miyazaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isao Miyazaki. Isao Miyazaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 3
2 0
3 1
4 8
5 11
6 9
7 7
8 11
9 1
10 42
11 5
12 12
13 8
14 29
15 0
16 43
17 26
18 28
19 116
20 11

About Isao Miyazaki

Isao Miyazaki is a scholar working on Genetics, Oncology and Nephrology, having authored 35 papers that have together received 651 indexed citations. Recurring topics across this work include Genetic and Kidney Cyst Diseases (8 papers), Renal and related cancers (6 papers) and Viral-associated cancers and disorders (5 papers). The work is most often cited by research in Otorhinolaryngology (49 citations), Oncology (251 citations) and Genetics (172 citations). Isao Miyazaki has collaborated with scholars based in Japan, Canada and United States. Frequent co-authors include Roy K. Cheung, Hans‐Michael Dosch, Siro Simizu, Hiroyuki Osada, Raphael Feinmesser, Hideo Okumura, Arnold M. Noyek, Jeremy L. Freeman, Satoshi Takagi and Eiji Higashihara. Their work appears in journals such as New England Journal of Medicine, The Journal of Experimental Medicine and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026